NCT05107856 2024-01-31PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesPrelude TherapeuticsPhase 1 Terminated21 enrolled
NCT02440685 2023-06-07A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsAsana BioSciencesPhase 1/2 Terminated51 enrolled 18 charts
NCT01474681 2020-12-30Safety and Tolerability of HSC835 in Patients With Hematological MalignanciesNovartisPhase 1/2 Completed27 enrolled 15 charts
NCT00891137 2014-10-27Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCellerant TherapeuticsPhase 1 Completed30 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts